Conmed (CNMD) reported $1.4B in revenue for fiscal 2025, +5.2% year on year. That ranks #1574 by revenue among 2853 SEC filers and #145 in Healthcare. Net income was $47.1M, a net margin of 3.4%. Revenue has grown 6.8% a year on average since 2016 ($764M then). The fiscal 2025 balance sheet shows $2.3B in total assets, $40.8M in cash and $834M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.4B | +5.2% | FY20252025-12-31 |
| Gross profitGrossProfit | $750M | +2.4% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $103M | −48.8% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $47.1M | −64.4% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $171M | +2.2% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $19.8M | +51.4% | FY20252025-12-31 |
| Total assetsAssets | $2.3B | +0.8% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $1.0B | +7.3% | FY20252025-12-31 |
| CashCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $40.8M | +66.9% | FY20252025-12-31 |
| Long-term debtLongTermDebtAndCapitalLeaseObligations | $834M | −7.8% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q2 20262026-06-30 | $343M | $23.1M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 96 of 161 companies compared | 3.4% | |
| Operating marginRank 98 of 160 companies compared | 7.5% | |
| R&D as share of revenueRank 82 of 102 companies compared | 4.1% | |
| Cash as share of revenueRank 141 of 160 companies compared | 3.0% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Conmed Corp
- Ticker
- CNMD
- Exchange
- NYSE
- SIC classification
- Electromedical & Electrotherapeutic Apparatus (3845)
- Fiscal year end
- 12-31
- CIK
- 0000816956
Filings
- 10-QJul 29, 2026Open filing →
- 10-QApr 30, 2026Open filing →
- 10-KFeb 17, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| PenumbraPEN | $1.4B | $178M |
| Halozyme TherapeuticsHALO | $1.4B | $317M |
| LivanovaLIVN | $1.4B | −$243M |
| ConmedCNMD | $1.4B | $47.1M |
| Stevanato GroupSTVN | $1.3B | $158M |
| HaemoneticsHAE | $1.3B | $97,308 |
| Phibro Animal HealthPAHC | $1.3B | $48.3M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Conmed — Key figures |url=https://companiesranked.com/en/company/conmed |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Conmed — Key figures. CompaniesRanked. https://companiesranked.com/en/company/conmedBibTeX
@misc{companiesranked-en-company-conmed-2026,
author = {{CompaniesRanked}},
title = {{Conmed — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/conmed}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000816956-26-000009 · February 17, 2026
{{cite web |title=Conmed — Key figures — 10-K (0000816956-26-000009) |url=https://www.sec.gov/Archives/edgar/data/816956/000081695626000009/cnmd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.